SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan

Coronavirus disease 2019 (COVID-19) has become a serious public health problem worldwide. In general, healthcare workers are considered to be at higher risk of COVID-19 infection. However, the prevalence of COVID-19 among healthcare workers in Japan is not well characterized. In this study, we aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshihara, Tatsuya, Ito, Kazuya, Zaitsu, Masayoshi, Chung, Eunhee, Aoyagi, Izumi, Kaji, Yoshikazu, Tsuru, Tomomi, Yonemura, Takuma, Yamaguchi, Koji, Nakayama, Shinichi, Tanaka, Yosuke, Yurino, Nobuo, Koyanagi, Hideki, Matsuki, Shunji, Urae, Ryuji, Irie, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038556/
https://www.ncbi.nlm.nih.gov/pubmed/33916399
http://dx.doi.org/10.3390/ijerph18073786
Descripción
Sumario:Coronavirus disease 2019 (COVID-19) has become a serious public health problem worldwide. In general, healthcare workers are considered to be at higher risk of COVID-19 infection. However, the prevalence of COVID-19 among healthcare workers in Japan is not well characterized. In this study, we aimed to examine the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies among 2160 healthcare workers in hospitals and clinics that are not designated to treat COVID-19 patients in Japan. The prevalence of SARS-CoV-2 immunoglobulin G was 1.2% in August and October 2020 (during and after the second wave of the pandemic in Japan), which is relatively higher than that in the general population in Japan (0.03–0.91%). Because of the higher risk of COVID-19 infection, healthcare workers should be the top priority for further social support and vaccination against SARS-CoV-2.

Ejemplares similares